Business Insurance

Login  |  Register Subscribe



Pfizer RSV vaccine for infants has 'generally favorable' safety data, FDA staff say

The FDA is slated to make a decision on whether to approve Pfizer's shot in August, just before respiratory syncytial virus season in the fall.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance Webinars & Webcasts

August 12: "Get Retrofit: Insurance Savings from Property Upgrades"

August 7: "Friends & Foes: Best Practices for Social Media Risk Management"

August 17: "Supply Chain Crisis?Navigating Business Interruption Coverage and Claims After the Japanese Earthquakes"

September 8: "Dormant Dangers: Protecting Key Corporate Assets from Cyber Attacks"

View all webcasts & webinars


Business Insurance Upcoming Issues

Aug. 22/29: Industry Financials: First-Half Results
Health Care Reform: Impact on Firms

September 5: Special Report: Alternative Risks

September 12: Workers Comp & Safety Management

View editorial calendar
Subscribe to Business Insurance